-
KCNE4-Dependent Modulation of Kv1.3 Pharmacology
2026-09-17
The reference study shows that the auxiliary subunit KCNE4 changes Kv1.3 pharmacology in a blocker- and stoichiometry-dependent manner. Although KCNE4 did not substantially alter apparent blocker affinity, it slowed intracellular Psora-4 inhibition, emphasizing that channel architecture and assay kinetics are important variables in Kv1.3-focused immunology.
-
Triamcinolone B1859: Research Workflow Guide
2026-09-17
Triamcinolone B1859 provides a defined synthetic glucocorticoid agonist for controlled studies of glucocorticoid receptor signaling, inflammation, and immunosuppression. This guide addresses solvent selection, stock handling, controls, and QC; the compound is for scientific research only and should not be used for diagnostic, therapeutic, or clinical purposes.
-
DT-TRAP Improves Chemoproteomic Target Recognition
2026-09-16
DT-TRAP streamlines target-responsive accessibility profiling by combining a simplified three-dose design with controlled low-temperature incubation. In the reference study, three-dose experiments and 4 °C incubation improved target specificity while reducing the material and instrument burden associated with conventional dose-gradient workflows.
-
CCK-8 Anxiolysis in Morphine-Withdrawal Rats
2026-09-16
The 2014 Neuroscience study showed that central CCK-8 reduces withdrawal-associated anxiety-like behavior in morphine-dependent rats through CCK1 receptor signaling and endogenous opioid involvement. Its antagonist experiments distinguish this effect from the better-known anxiogenic actions of other CCK forms and provide a mechanistic framework for studying negative affect during opioid abstinence.
-
Anti-HMGB1 Rabbit Monoclonal Antibody Guide
2026-09-15
This guide explains how to use the Anti-HMGB1 Rabbit Monoclonal Antibody, SKU MA3057, for controlled detection of HMGB1 in human, mouse, and rat samples. It supports Western blot, frozen and paraffin immunohistochemistry, and flow cytometry workflows, but it is not validated here for diagnostic, therapeutic, medical, or unsupported assay applications.
-
L-NMMA acetate in Reliable NO Assays
2026-09-15
This scenario-based guide shows how L-NMMA acetate, SKU B6444, can strengthen viability, proliferation, and cytotoxicity workflows that interrogate nitric oxide signaling. It combines literature evidence, practical controls, protocol parameters, and product-selection criteria for more interpretable NOS experiments.
-
CX-5461: From rRNA Stress to Cancer Assays
2026-09-14
CX-5461 is an RNA polymerase I inhibitor that converts ribosome-biogenesis stress into measurable DNA-damage, senescence, autophagy, and mitotic outcomes. This guide develops an assay-centered framework for interpreting its activity across cancer research models and combination studies.
-
BX795: PDK1 Inhibitor for Kinase Research
2026-09-14
BX795 is an ATP-competitive PDK1 inhibitor with additional TBK1 and IKKε activity. Its profile supports controlled studies of PI3K/Akt/mTOR signaling, cancer cell growth inhibition, and innate immune response modulation.
-
Acetylspiramycin: From Ribosome to Translation
2026-09-13
Acetylspiramycin, also known as Spiramycin B, offers translational researchers a useful bridge between ribosomal inhibition, antimicrobial resistance research, and host-response biology. This thought-leadership article explains how to validate its activity, interpret a revealing ocular toxoplasmosis case, and design more decision-ready studies without overstating clinical evidence.
-
I-BET-762: Selective BET Inhibitor Guide
2026-09-12
I-BET-762 is a potent BET inhibitor that competitively occupies the acetyl-lysine binding pocket of BET proteins. Preclinical evidence supports its use in transcriptional regulation, inflammation research, and ferroptosis-oriented cancer biology studies, but the compound is not a clinical treatment.
-
From Cardiac Maps to Blebbistatin Cell Mechanics
2026-09-11
A structure–function framework for using (±)-Blebbistatin to connect non-muscle myosin II activity with spatial changes in cell migration, adhesion, and morphology.
-
Anti-HMGB1 Rabbit Monoclonal Antibody Guide
2026-09-11
The Anti-HMGB1 Rabbit Monoclonal Antibody, SKU MA3057, supports research detection of HMGB1 in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. It should be used as an analytical reagent after in-laboratory optimization and is not intended for diagnostic, therapeutic, or other medical applications.
-
Rocket-Like Nanomedicine Reprograms PDAC Stroma
2026-09-10
Fu and colleagues developed an acid-responsive Si-G@Ca-H/uPA nanoplatform that remodels pancreatic ductal adenocarcinoma stroma before releasing gemcitabine more deeply. In a PDAC mouse model, sequential stromal intervention was associated with marked tumor regression without reported overt side effects, supporting stromal homeostasis restoration as an alternative to broad stromal depletion.
-
KR-12 Human Antimicrobial Peptide: Workflow Guide
2026-09-10
KR-12 combines membrane-active antibacterial activity with anti-biofilm, LPS-neutralizing, and inflammation-focused research potential. This practical guide translates published colitis findings into assay design, formulation, controls, and troubleshooting strategies for researchers using the TFA salt.
-
BCA Protein Quantification Kit K4102 Guide
2026-09-09
The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 supports sensitive total-protein measurement when dilute samples, cell lysates, or detergent-containing preparations must be normalized. It is intended for scientific research workflows only and should not be used for diagnostic, clinical, or medical testing.